ArticleKidney medicine2023

Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States.

Susanne B Nicholas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.